BROOKSTONE CAPITAL MANAGEMENT – Gilead Sciences, Inc. Transaction History
BROOKSTONE CAPITAL MANAGEMENT portfolio value:
$11.06M
portfolio value
BROOKSTONE CAPITAL MANAGEMENT quarter portfolio value change:
-0.19%
quarter
Gilead Sciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +5.72% | 9.14K shares | 1.00M | $61.69 | 169.16K |
| Q2 2022 | share | Increase | +52.93% | 55.37K shares | 3.57M | $61.81 | 160.01K |
| Q1 2022 | share | Increase | +38.12% | 28.88K shares | 1.07M | $59.45 | 104.63K |
| Q4 2021 | share | Decrease | -0.58% | -439 shares | 245K | $73.36 | 75.75K |
| Q3 2021 | share | Increase | +20.12% | 12.76K shares | 839K | $69.85 | 76.19K |
| Q2 2021 | share | Increase | +24.59% | 12.51K shares | 1.02M | $68.17 | 63.43K |
| Q1 2021 | share | Decrease | -1.85% | -959 shares | 269K | $63.33 | 50.91K |
| Q4 2020 | share | Increase | +15.28% | 6.87K shares | 178K | $56.43 | 51.87K |
| Q3 2020 | share | Increase | +42.92% | 13.51K shares | 421K | $60.52 | 45K |
| Q2 2020 | share | Decrease | -19.55% | -7.65K shares | -503K | $72.94 | 31.48K |
| Q1 2020 | share | Increase | 0.00% | 39.13K shares | 2.92M | $70.22 | 39.13K |
| Q4 2019 | share | Decrease | -100.00% | -18.04K shares | -1.14M | $60.43 | 0 |
| Q3 2019 | share | Decrease | -47.69% | -16.45K shares | -1.18M | $58.4 | 18.04K |
| Q2 2019 | share | Increase | 0.00% | 34.50K shares | 2.33M | $61.67 | 34.50K |
| Q4 2018 | share | Decrease | -100.00% | -63.47K shares | -4.90M | $56.02 | 0 |
| Q3 2018 | share | Decrease | -9.58% | -6.72K shares | -72K | $68.57 | 63.47K |
| Q2 2018 | share | Decrease | -3.24% | -2.34K shares | -497K | $62.43 | 70.20K |
| Q1 2018 | share | Increase | +2.58% | 1.82K shares | 403K | $65.91 | 72.55K |
| Q4 2017 | share | Increase | 0.00% | 70.72K shares | 5.06M | $62.19 | 70.72K |